PH22843A - Nitrofurantoin dosage form - Google Patents

Nitrofurantoin dosage form

Info

Publication number
PH22843A
PH22843A PH35401A PH35401A PH22843A PH 22843 A PH22843 A PH 22843A PH 35401 A PH35401 A PH 35401A PH 35401 A PH35401 A PH 35401A PH 22843 A PH22843 A PH 22843A
Authority
PH
Philippines
Prior art keywords
dosage form
nitrofurantoin
nitrofurantoin dosage
dosage
Prior art date
Application number
PH35401A
Other languages
English (en)
Inventor
Vikram Suresh Patel
Welles Harry Leslie
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of PH22843A publication Critical patent/PH22843A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH35401A 1986-06-16 1987-06-15 Nitrofurantoin dosage form PH22843A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/874,943 US4772473A (en) 1986-06-16 1986-06-16 Nitrofurantoin dosage form

Publications (1)

Publication Number Publication Date
PH22843A true PH22843A (en) 1989-01-19

Family

ID=25364916

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35401A PH22843A (en) 1986-06-16 1987-06-15 Nitrofurantoin dosage form

Country Status (13)

Country Link
US (1) US4772473A (de)
EP (1) EP0250023B1 (de)
JP (1) JP2509226B2 (de)
AT (1) AT398166B (de)
AU (1) AU592731B2 (de)
CA (1) CA1288050C (de)
DE (1) DE3772113D1 (de)
DK (1) DK173432B1 (de)
IE (1) IE60661B1 (de)
IL (1) IL82807A (de)
NZ (1) NZ220695A (de)
PH (1) PH22843A (de)
ZA (1) ZA874316B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917892A (en) * 1988-06-28 1990-04-17 Temple University Encapsulated topical delivery system
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
US5670111A (en) 1990-01-10 1997-09-23 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
US5261896A (en) * 1990-01-10 1993-11-16 Rochester Medical Corporation Sustained release bactericidal cannula
US5971954A (en) * 1990-01-10 1999-10-26 Rochester Medical Corporation Method of making catheter
US5360402A (en) * 1990-01-10 1994-11-01 Rochester Medical Corporation Hand-actuated retention catheter
US6626888B1 (en) 1990-01-10 2003-09-30 Rochester Medical Corporation Method of shaping structures with an overcoat layer including female urinary catheter
US5269770A (en) * 1990-01-10 1993-12-14 Rochester Medical Corporation Microcidal agent releasing catheter with balloon
AU769224B2 (en) * 1998-12-28 2004-01-22 Taisho Pharmaceutical Co., Ltd. External preparation
IL150053A0 (en) * 1999-12-06 2002-12-01 Mendell Co Inc Edward Pharmaceutical superdisintegrant
RU2325152C2 (ru) * 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
PA8578501A1 (es) * 2002-07-25 2005-02-04 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
WO2004017938A2 (en) * 2002-08-23 2004-03-04 Ranbaxy Laboratories Limited Nitrofurantoin controlled release dosage form
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
CN101022788B (zh) 2004-08-13 2010-11-10 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放小球制剂、其制备方法及其用途
UA93608C2 (ru) * 2004-08-13 2011-02-25 Берингер Ингельхайм Интернациональ Гмбх композициЯ таблетки пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, СПОСОБ EE ИЗГОТОВЛЕНИЯ И EE ПРИМЕНЕНИЕ
US8864730B2 (en) 2005-04-12 2014-10-21 Rochester Medical Corporation Silicone rubber male external catheter with absorbent and adhesive
US20080095844A1 (en) * 2006-10-23 2008-04-24 Rajhans Sujay Kamalakar Sustained release pharmaceutical compositions of alfuzosin and process for preparation thereof
US8603200B2 (en) * 2009-06-22 2013-12-10 Afton Chemical Corporation Compositions comprising combustion improvers and methods of use thereof
CN102000041A (zh) * 2010-11-19 2011-04-06 合肥合源药业有限公司 含有速释和缓释两种成分的呋喃坦啶胶囊及其制备方法
US9707375B2 (en) 2011-03-14 2017-07-18 Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. Catheter grip and method
US9872969B2 (en) 2012-11-20 2018-01-23 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Catheter in bag without additional packaging
US10092728B2 (en) 2012-11-20 2018-10-09 Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. Sheath for securing urinary catheter
CA2957085C (en) 2014-08-26 2023-01-17 C.R. Bard, Inc. Packaging and hydrophilic coating of urinary catheter
EP3675779B1 (de) 2017-09-19 2025-09-10 C. R. Bard, Inc. Vorrichtung zur überbrückung von harnkathetern, systeme und verfahren dafür
EP4364777B1 (de) 2020-08-03 2026-05-06 C. R. Bard, Inc. Intermittierende katheteranordnungen und verfahren dafür
US12611519B2 (en) 2020-09-11 2026-04-28 C. R. Bard, Inc. Intermittent-catheter assembly and methods thereof
EP4285895A1 (de) * 2022-06-03 2023-12-06 Adalvo Limited Orale dosierungsform von nitrofurantoin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL171628C (nl) * 1950-05-29 Inst Francais Du Petrole Inrichting voor het uitzenden van akoestische golven in een vloeibaar milieu.
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
US3427378A (en) * 1965-02-12 1969-02-11 American Cyanamid Co Sustained release encapsulated formula
GB1093286A (en) * 1965-02-15 1967-11-29 Biorex Laboratories Ltd Improvements in or relating to dosage unit forms for the administration of medicaments and diagnostic agents
US3458622A (en) * 1967-04-07 1969-07-29 Squibb & Sons Inc Controlled release tablet
GB1204580A (en) * 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3634584A (en) * 1969-02-13 1972-01-11 American Home Prod Sustained action dosage form
US3851051A (en) * 1970-07-17 1974-11-26 Scherer R Corp Soft gelatin capsule containing high water content fill
US4152444A (en) * 1972-04-19 1979-05-01 Ciba-Geigy Corporation Pharmaceutical compound preparations with bactericidal action
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication
FR2407720A1 (fr) * 1977-11-08 1979-06-01 Lipha Lyonnaise Indle Pharmace Preparations pharmaceutiques orales a activite therapeutique prolongee
US4247552A (en) * 1979-01-11 1981-01-27 Syntex (U.S.A.) Inc. Contraceptive compositions and methods employing 1-substituted imidazole derivatives
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
US4252786A (en) * 1979-11-16 1981-02-24 E. R. Squibb & Sons, Inc. Controlled release tablet
US4370313A (en) * 1981-10-26 1983-01-25 Eaton Laboratories, Inc. Nitrofurantoin dosage form
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule

Also Published As

Publication number Publication date
AU592731B2 (en) 1990-01-18
DK306487A (da) 1987-12-17
IE60661B1 (en) 1994-08-10
ATA151687A (de) 1994-02-15
NZ220695A (en) 1990-08-28
EP0250023B1 (de) 1991-08-14
US4772473A (en) 1988-09-20
AT398166B (de) 1994-10-25
DE3772113D1 (de) 1991-09-19
DK306487D0 (da) 1987-06-16
IL82807A (en) 1991-12-12
DK173432B1 (da) 2000-10-23
ZA874316B (en) 1988-08-31
IL82807A0 (en) 1987-12-20
IE871585L (en) 1987-12-16
AU7421187A (en) 1987-12-17
JP2509226B2 (ja) 1996-06-19
EP0250023A1 (de) 1987-12-23
JPS63258420A (ja) 1988-10-25
CA1288050C (en) 1991-08-27

Similar Documents

Publication Publication Date Title
ZA874316B (en) Nitrofurantoin dosage form
GB2210266B (en) Dosage form
GR3002559T3 (en) Continuous pelleting-process
AR243868A1 (es) Procedimiento para obtener 3-fenoxi o 3-naftiloxi propanaminas-3-sustituidas y sus sales
GB8607178D0 (en) Dosage means
GB2188255B (en) Tankwasher
GB8708225D0 (en) Dosage form
EP0250817A3 (en) Distributer
CA57305S (en) Dictating-machine
CA56175S (en) Presse-ail
CA56534S (en) Boardgame
CA57727S (en) Loudspeaker-cabinet
CA56801S (en) Eyeguard
CA55743S (en) Boardgame
CA57366S (en) Loudspeaker-cabinet
CA57574S (en) Vitrine
CA57575S (en) Vitrine
CA57624S (en) Chemisier
CS909586A1 (en) Linear dosage
CS439886A1 (en) Zavesne tahadlo viek vozikovej vypevcej form
AU97795S (en) Craypot upper
CS925586A1 (en) Staticky snimac uhlu naklonu normaly roviny od vertikaly
BG43026A1 (en) Lyposomic pharmaceutical form
AU100631S (en) Wax-applicator
AU102471S (en) Dollshouse